Nampota-NkombaNNyirendaOMKhondeL, et al. Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested sub study of a double-blind, randomized controlled trial. Lancet Glob Health. 2022;10(9):e1326-e1335. doi:10.1016/S2214-109X(22)00275-3
4.
YousafzaiMTHeywoodAE.Typhoid conjugate vaccine: are we heading towards the elimination of typhoid in endemic countries?Lancet Glob Health. 2022;10(9):e1224-e1225. doi:10.1016/S2214-109X(22)00328-X
5.
QamarFNYousafzaiMTKhalidMKaziAMLohanaHKarimS, et al. Outbreak investigation of ceftriaxone-resistant Salmonella enterica serotype Typhi and its risk factors among the general population in Hyderabad, Pakistan: a matched case-control study. Lancet Infect Dis. 2018;18(12):1368-1376. doi:10.1016/S1473-3099(18)30483-3
6.
SinghalLGuptaPKKalePGautamVRayP.Trends in antimicrobial susceptibility of Salmonella typhi from North India (2001-2012). Indian J Med Microbiol. 2014;32(2):149-152. doi:10.4103/0255-0857.129799
7.
SahRDonovanSSeth-SmithHMB, et al. A novel lineage of ceftriaxone-resistant Salmonella typhi from India that is closely related to XDR S. Typhi found in Pakistan. Clin Infect Dis. 2020;71(5):1327-1330. doi:10.1093/cid/ciz1204